| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.48 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |